<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">946524</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2022.946524</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Activation of CCL21-GPR174/CCR7 on cardiac fibroblasts underlies myocardial ischemia/reperfusion injury</article-title>
<alt-title alt-title-type="left-running-head">Meng et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2022.946524">10.3389/fgene.2022.946524</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Meng</surname>
<given-names>Xiao-Wen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1513811/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Mian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1370349/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Jun-Kai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1820958/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xin-Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Long</surname>
<given-names>Yu-Qin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1262347/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Hong</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/976245/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Xiao-Mei</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1851076/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ji</surname>
<given-names>Fu-Hai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/773650/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Peng</surname>
<given-names>Ke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1182244/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Anesthesiology</institution>, <institution>First Affiliated Hospital of Soochow University</institution>, <addr-line>Suzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Anesthesiology</institution>, <institution>Soochow University</institution>, <addr-line>Suzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Anesthesiology and Pain Medicine</institution>, <institution>Davis Health System</institution>, <institution>University of California, Davis</institution>, <addr-line>Sacramento</addr-line>, <addr-line>CA</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Anesthesiology</institution>, <institution>University of Utah</institution>, <addr-line>Salt Lake City</addr-line>, <addr-line>UT</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/113217/overview">Suowen Xu</ext-link>, University of Science and Technology of China, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/201704/overview">Zhengyuan Xia</ext-link>, The University of Hong Kong, Hong Kong, SAR China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/934201/overview">Mohammed Imad Malki</ext-link>, Qatar University, Qatar</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Fu-Hai Ji, <email>jifuhaisuda@163.com</email>; Ke Peng, <email>pengke0422@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>946524</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>05</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>08</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Meng, Zhang, Hu, Chen, Long, Liu, Feng, Ji and Peng.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Meng, Zhang, Hu, Chen, Long, Liu, Feng, Ji and Peng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> The mechanisms underlying myocardial ischemia/reperfusion (I/R) injury are not fully understood. This study aims to explore key candidate genes and potential therapeutic targets for treatment of myocardial I/R injury.</p>
<p>
<bold>Methods:</bold> The transcriptional profiles of ventricular myocardium during cardiac arrest, ischemia, and reperfusion were obtained from the Gene Expression Omnibus database. Based on the transcriptional data of GSE6381, functional pathway and process enrichment analyses, protein&#x2013;protein interaction network, and gene set enrichment analyses were conducted. In the animal experiments, we established the myocardial I/R injury model in mice. We validated the mRNA and protein expression of the key genes using the qPCR and western blots. We further assessed the expression and localization of CCL21 and its receptors using immunofluorescence staining experiments.</p>
<p>
<bold>Results:</bold> The microarray analyses identified five key genes (<italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, <italic>EDN1</italic>, and <italic>CASR</italic>). Myocardial I/R process in mice resulted in significant myocardial infraction, histological damage, and myocardial apoptosis. The results of qPCR and western blots showed that the expression of CCL21 and CXCL13 were increased following myocardial I/R injury in mice. Furthermore, the immunofluorescence staining results revealed that the expression of GPR174/CCR7 (CCL21 receptors), but not CXCR5 (CXCL13 receptor), was elevated following myocardial I/R injury. Moreover, the activated CCL21-GPR174/CCR7 signaling was located on the cardiac fibroblasts of the myocardium with I/R injury.</p>
<p>
<bold>Conclusion:</bold> This study revealed several key factors underlying myocardial I/R injury. Of these, the activation of CCL21-GPR174/CCR7 signaling on cardiac fibroblasts was highlighted, which provides potential therapeutic targets for cardioprotection.</p>
</abstract>
<kwd-group>
<kwd>myocardial ischemia/reperfusion injury</kwd>
<kwd>differentially expressed genes</kwd>
<kwd>CCL21</kwd>
<kwd>GPR174/CCR7</kwd>
<kwd>cardiac fibroblasts</kwd>
<kwd>transcriptome</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Science Foundation of Jiangsu Province<named-content content-type="fundref-id">10.13039/501100004608</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Timely restoration of blood flow is the most effective therapeutic strategy to salvage the viable myocardium for patients with acute myocardial infarction (<xref ref-type="bibr" rid="B21">Moran et al., 2014</xref>). Nevertheless, reperfusion <italic>per se</italic> leads to myocardial ischemia/reperfusion (I/R) injury, a complex pathophysiological process contributing up to 50% of final myocardial infarct size (<xref ref-type="bibr" rid="B3">Boag et al., 2015</xref>). Several characteristics of myocardial I/R injury are inflammatory responses, reactive oxygen species accumulation, cell apoptosis, and intracellular calcium overload (<xref ref-type="bibr" rid="B11">Hausenloy and Yellon, 2013</xref>; <xref ref-type="bibr" rid="B41">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="B9">Ge et al., 2019</xref>; <xref ref-type="bibr" rid="B40">Yuan et al., 2019</xref>). Despite recent progresses attempting to attenuate myocardial I/R injury, it remains an unsolved problem.</p>
<p>During cardiac surgery under cardiopulmonary bypass, myocardial I/R injury is predictable and inevitable (<xref ref-type="bibr" rid="B4">Bulluck et al., 2016</xref>). Compared with an unprotected myocardial I/R process, blood cardioplegic arrest and protective hypothermia are utilized to limit myocardial injury. A previous study assessed the gene expression profiles of myocardium in the early I/R stages in cardiac surgery using the microarray approach (<xref ref-type="bibr" rid="B1">Arab et al., 2007</xref>). Their results suggested that multiple signaling pathways such as PI3K signaling and hemoglobin synthesis were activated during the process (<xref ref-type="bibr" rid="B1">Arab et al., 2007</xref>). That study showed gene expression profiles only, without any further analysis or experimental validation. To date, the mechanisms of myocardial I/R injury are not fully understood.</p>
<p>This study aimed to explore the key genes and pathways in myocardial I/R injury. Through analyzing the transcriptional data, differentially expressed genes (DEGs) were identified from the Gene Expression Omnibus (GEO) database, and functional pathway and process enrichment analyses were performed. For the key genes, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein&#x2013;protein interaction (PPI) were investigated. Gene set enrichment analysis (GSEA) was used to reveal enriched pathways in the stages of ischemia and reperfusion. Finally, the expression of key candidate genes was assessed in myocardial I/R injury of mice, and the activation of CCL21 with its receptors GPR174/CCR7 was highlighted.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Data acquisition and differentially expressed genes identification</title>
<p>The gene expression profile dataset GSE6381 was downloaded from the GEO database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>). GSE6381 presented early gene expression profiles during intraoperative myocardial I/R in cardiac surgery under cardiopulmonary bypass. Specifically, human right ventricular samples were obtained during surgical repair of ventricular septal defect and resection of right ventricular outflow obstruction, with four replicates at each stage (immediately post-cardioplegic arrest, end-ischemia, and 5&#xa0;min after reperfusion). Data were detected on the Affymetrix Human Genome U133A Array platform (GPL96). The limma package in R language was used to identify DEGs for end-ischemia vs. cardiac arrest, reperfusion vs. end-ischemia, and reperfusion vs. cardiac arrest, respectively (<xref ref-type="bibr" rid="B25">Ritchie et al., 2015</xref>). The thresholds for DEGs selection were set as <italic>p</italic> &#x3c; 0.05 and log<sub>2</sub> FC (fold change) &#x3e; 1. Volcano plots and heatmaps were generated to overview the gene expression profiles by using the R package.</p>
</sec>
<sec id="s2-2">
<title>Pathway and process enrichment analyses of differentially expressed genes</title>
<p>For the DEGs from each comparison, pathway and process enrichment analyses were performed by using the Metascape (<ext-link ext-link-type="uri" xlink:href="http://metascape.org/">http://metascape.org/</ext-link>) (<xref ref-type="bibr" rid="B44">Zhou et al., 2019</xref>). The analyses were based on the following databases: GO Biological Processes, KEGG Pathways, Reactome Gene Sets, and Canonical Pathways. Terms with count &#x2265;3, <italic>p</italic>-value &#x3c; 0.01, and enrichment factor (observed counts/counts expected by chance) &#x3e;1.5 were grouped in clusters based on the similarities. Specifically, <italic>p</italic>-values were calculated based on the accumulative hypergeometric distribution, and q-values were calculated by using the Banjamini-Hochberg procedure for multiple testing (<xref ref-type="bibr" rid="B12">Hochberg and Benjamini, 1990</xref>). Hierarchical clustering was performed on the enriched terms with the kappa scores, and sub-trees with a similarity &#x3e;0.3 were considered a cluster (<xref ref-type="bibr" rid="B26">Roberts, 2008</xref>). The most statistically significant term within a cluster was used to represent the cluster. The overlaps between three gene lists were shown in a Circos plot (<xref ref-type="bibr" rid="B17">Krzywinski et al., 2009</xref>). Heatmaps of the top 20 and 100 enriched terms were generated by using the JTreeView (<xref ref-type="bibr" rid="B27">Saldanha, 2004</xref>).</p>
</sec>
<sec id="s2-3">
<title>Networks of significantly enriched terms</title>
<p>To further investigate the relationships among the enriched terms, network plots of the top 20 clusters were generated, where terms with a similarity &#x3e;0.3 were connected by edges. The networks were visualized by using the Cytoscape software v3.7.2 (<ext-link ext-link-type="uri" xlink:href="https://cytoscape.org/">https://cytoscape.org/</ext-link>), where each node represented an enriched term and was colored by its cluster ID and then by <italic>p</italic>-value (<xref ref-type="bibr" rid="B28">Shannon et al., 2003</xref>). In addition, the nodes were represented as pie charts, where the size of a pie was proportional to the total number of hits belonging to the specific term. The pie charts were color-coded based on the gene list identities, and the size of a slice showed the percentage of genes under the term which originated from the specific gene list.</p>
</sec>
<sec id="s2-4">
<title>Protein&#x2013;protein interaction network of differentially expressed genes and modular analysis</title>
<p>For all DEGs, PPI network analysis was carried out by using the Metascape. The analyses were based on several databases, including BioGrid, InWeb_IM, and OmniPath (<xref ref-type="bibr" rid="B31">Stark et al., 2006</xref>; <xref ref-type="bibr" rid="B34">Turei et al., 2016</xref>; <xref ref-type="bibr" rid="B18">Li et al., 2017</xref>). The resultant network contained the subset of proteins with at least one physical interaction with one other member. The Molecular Complex Detection (MCODE) algorithm was applied to identify highly connected network components (<xref ref-type="bibr" rid="B2">Bader and Hogue, 2003</xref>). The PPI network plots were visualized by using the <ext-link ext-link-type="uri" xlink:href="http://www.cytoscape.org/">Cytoscape</ext-link>, where each node represented a hub protein and was colored by the cluster ID and gene list identity.</p>
</sec>
<sec id="s2-5">
<title>Functional enrichment of 26 key genes</title>
<p>For the 26 key genes identified in MOCDE 1, GO enrichment analyses of biological process (BP), molecular function (MF), and cellular component (CC) were conducted by using the gProfiler (<ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/gprofiler/">https://biit.cs.ut.ee/gprofiler/</ext-link>) (<xref ref-type="bibr" rid="B24">Raudvere et al., 2019</xref>). In addition, KEGG pathway analysis was performed to analyze significantly enriched signaling pathways. A <italic>p</italic>-value &#x3c; 0.05 was applied as the threshold value.</p>
</sec>
<sec id="s2-6">
<title>Protein&#x2013;protein interaction analysis of 26 key genes</title>
<p>By using the GeneMANIA (<ext-link ext-link-type="uri" xlink:href="http://genemania.org/">http://genemania.org/</ext-link>), a flexible and user-friendly web interface, PPI network and functional assays of 26 key genes were generated and visualized (<xref ref-type="bibr" rid="B45">Zuberi et al., 2013</xref>). Several types of relationships among proteins included co-expressions, physical interactions, shared protein domains, pathways, website predictions, co-localizations, and genetic interactions. GeneMANIA also reported weights that indicated the predictive value of each selected data set.</p>
</sec>
<sec id="s2-7">
<title>Gene set enrichment analysis of ischemia and reperfusion samples</title>
<p>GSEA is a computational method used to determine whether a predefined set of genes shows significant and concordant differences between the two study groups. GSEA software v3.0 (<ext-link ext-link-type="uri" xlink:href="http://www.gsea-msigdb.org/gsea/">http://www.gsea-msigdb.org/gsea/</ext-link>) was used to perform KEGG pathway enrichment for two comparisons: end-ischemia vs. cardiac arrest and reperfusion vs. cardiac arrest (<xref ref-type="bibr" rid="B32">Subramanian et al., 2005</xref>). A <italic>p</italic>-value &#x3c; 0.05 was considered as statistically significant. The &#x201c;c2.cp.kegg.v6.2.symbols.gmt&#x201d; gene set was downloaded from the Molecular Signatures Database and used as the reference gene set.</p>
</sec>
<sec id="s2-8">
<title>Myocardial I/R injury in mice</title>
<p>The protocol of animal study was approved by the Ethic Committee for Animal Care and Use at Soochow University, Suzhou, Jiangsu, China. The animal experimental procedures followed the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication No. 85-23, revised in 1996). Adult male C57BL/6J mice (8&#xa0;weeks old, 20&#x2013;25&#xa0;g) were provided by the Experimental Animal Center of Soochow University. Mice were housed in a controlled condition (temperature of 24&#x2013;26&#xb0;C, 12-h light/dark cycle, and free access to food and water).</p>
<p>We induced myocardial I/R injury in mice as previously reported (<xref ref-type="bibr" rid="B23">Peng et al., 2021</xref>). First, the mice were anesthetized with intraperitoneal sodium pentobarbital (50&#xa0;mg/kg). Next, the mice were endotracheally intubated and received mechanical ventilation using a rodent respirator (RWD, Shenzhen, China). A left thoracotomy was performed in the left fourth intercostal space. The left anterior descending coronary artery (LAD) was temporarily ligated at &#x223c;2&#xa0;mm under the lower edge of the left auricle. Observation of tissue blanching in the left ventricular myocardium and elevation in the ST-segment of electrocardiography indicated that the myocardial I/R model was successfully established. The LAD was occluded for 30&#xa0;min to induce myocardial ischemia, and the ligature was removed for reperfusion of 30&#xa0;min. For mice in the sham surgery group, the same surgical procedure was performed except that the suture placed around the LAD was not tied. At the end of the reperfusion, the hearts were harvested.</p>
</sec>
<sec id="s2-9">
<title>Area at risk and infarct size of myocardium</title>
<p>Evans blue staining and 2,3,5-triphenyltetrazolium chloride (TTC) staining were used to assess the area at risk and infarct size of myocardium, as previously described (<xref ref-type="bibr" rid="B22">Peng et al., 2020</xref>; <xref ref-type="bibr" rid="B30">Song et al., 2020</xref>; <xref ref-type="bibr" rid="B37">Yang et al., 2021</xref>). Briefly, the LAD was re-ligated following 30&#xa0;min of reperfusion, and 1&#xa0;ml of 2% Evans blue dye (Sigma, St. Louis, MO) was perfused into the coronary artery. The heart was then immediately excised and quickly frozen at &#x2212;80&#xb0;C. The heart samples below the ligature were sliced into five transverse sections, and the slices were incubated with 1% TTC (Sigma, St. Louis, MO) at 37&#xb0;C for 15&#xa0;min in a dark chamber and fixed with 10% formaldehyde overnight. The non-ischemic area (blue), the myocardium area at risk (AAR, red), and infarct area (IA, pale) were measured using the Image Pro Plus software (Media Cybernetics, Silver Spring, MD, United States). The ratios of IA/AAR and AAR/left ventricular area (LV) were calculated.</p>
</sec>
<sec id="s2-10">
<title>Histological examination of myocardium</title>
<p>Histological structure of the left ventricular myocardium samples was detected using the hematoxylin and eosin (HE) staining (<xref ref-type="bibr" rid="B37">Yang et al., 2021</xref>). Briefly, myocardial tissues were fixed with paraformaldehyde and embedded with paraffin. The samples were cut transversely into 5&#xa0;&#xb5;m-thick sections. After dewaxing with dimethylbenzene and dehydrating with graded ethanol series, the slices were stained with hematoxylin and eosin. Finally, histological damage of the myocardium was observed under a light microscope (Nikon Corporation; Tokyo, Japan).</p>
</sec>
<sec id="s2-11">
<title>Myocardial apoptosis assay</title>
<p>Cell apoptosis in the left ventricular myocardium samples was assessed using the terminal deoxynucleotidyl transferase dUTP nick&#x2010;end labeling (TUNEL) analysis with the <italic>in situ</italic> Cell Death Detection kit (Roche Molecular Biochemicals, Mannheim, Germany) (<xref ref-type="bibr" rid="B22">Peng et al., 2020</xref>; <xref ref-type="bibr" rid="B23">Peng et al., 2021</xref>). The heart samples were fixed in 4% paraformaldehyde, dehydrated, embedded in paraffin, and cut into 4&#xa0;&#x3bc;m&#x2010;thick sections. The slices were incubated with TUNEL reaction mixture and then counterstained with the 4&#x2032;,6-diamino-2-phenylindole (DAPI) to show the nuclei. At least four random and nonoverlapping of views in areas surrounding the infarct area in the I/R group or the corresponding area in the sham group were observed using a fluorescence microscope (Nikon Corporation; Tokyo, Japan). The apoptosis rate was expressed as a percentage of TUNEL-positive cells to total cell nuclei.</p>
</sec>
<sec id="s2-12">
<title>Quantitative real-time polymerase chain reaction</title>
<p>Total RNA in the left ventricular myocardium samples was extracted using the TRIZOL reagent (Thermo Fisher Scientific, Waltham, MA). After RNA quantification and purity evaluation, reverse transcription was conducted with a cDNA Synthesis Kit (abm, Richmond, BC, Canada), in a 20&#xa0;&#x3bc;l reaction system containing 5&#xd7; All-in-one, DEPC water, and RNA samples. Then, qPCR was performed with the EvaGreen (abm, Richmond, BC, Canada) on the Roche Light Cycler R480 System (Roche, Bedford, MA). The amplification conditions were: Pre-denaturation at 93&#xb0;C for 10&#xa0;s, denaturation at 55&#xb0;C for 15&#xa0;s, and annealing at 72&#xb0;C for 20&#xa0;s for 40 cycles. Three replicates were used for each sample. Gene expression were analyzed by using the 2<sup>&#x2212;&#x394;&#x394;CT</sup> method and normalized to &#x3b2;-tubulin. The sequences of primers (Sangon Biotech, Shanghai, China) are listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Specific primers.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Oligo</th>
<th align="left">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">EDN1-F</td>
<td align="left">TTT TCC CGT GAT CTT CTC TCT G</td>
</tr>
<tr>
<td align="left">EDN1-R</td>
<td align="left">CAG AAG TAG ACA CAC TCC TTG T</td>
</tr>
<tr>
<td align="left">CASR-F</td>
<td align="left">ACA GGT TAC TCA ATA GCT CCA C</td>
</tr>
<tr>
<td align="left">CASR-R</td>
<td align="left">GTA CAC GTT GTA GGA TAT CCG T</td>
</tr>
<tr>
<td align="left">XCR1-F</td>
<td align="left">GGG TCT TGG TGA AGT ATG AGA A</td>
</tr>
<tr>
<td align="left">XCR1-R</td>
<td align="left">CTT GCA GAA GAA GTC ACC TAG A</td>
</tr>
<tr>
<td align="left">CCL21-F</td>
<td align="left">TTT TTA CCA AGT GGC CTC TGA A</td>
</tr>
<tr>
<td align="left">CCL21-R</td>
<td align="left">GCG TTG ATT TCA AAG TGG GTA A</td>
</tr>
<tr>
<td align="left">CXCL13-F</td>
<td align="left">TG TGA TCT GGA CCA AGA TGA A</td>
</tr>
<tr>
<td align="left">CXCL13-R</td>
<td align="left">GAC TTT TGC TTT GGA CAT GTC T</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-13">
<title>Western blots</title>
<p>The total protein of the left ventricular myocardium samples was extracted using the RIPA reagents (Beyotime, Shanghai, China). The protein concentrations were detected using a bicinchoninic acid protein assay kit (Beyotime, Shanghai, China). All proteins were separated with 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis, and transferred onto polyvinylidene fluoride membranes (Millipore Corp., Bedford, MA). The membranes were incubated with the primary antibodies overnight at 4&#xb0;C, and then incubated with the horseradish peroxidase-conjugated secondary antibodies for 2&#xa0;h at room temperature. The primary antibodies were as follows: goat anti-CCL21 (1:1000; R&#x26;D Systems, Minneapolis, MN), rabbit anti-XCR1 (1:1000; Novus Biologicals, Littleton, CO), goat anti-CXCL13 (1:1000; R&#x26;D Systems, Minneapolis, MN), goat anti-CCR7 (1:1000; Novus Biologicals, Littleton, CO), rabbit anti-GPR174 (1:1000; Biorbyt, Cambridge, United Kingdom), rabbit anti-CXCR5 (1:1000; Absin, Shanghai, China), and rabbit anti-&#x3b2;-tubulin (1:5000; Cell Signaling Technology, Beverly, MA). Finally, the protein bands were detected using the Tanon 5200 luminescent workstation (Tanon, Shanghai, China). The protein expression was normalized to &#x3b2;-tubulin as control.</p>
</sec>
<sec id="s2-14">
<title>Immunofluorescence staining</title>
<p>Following 30&#xa0;min of reperfusion, the left ventricular myocardium samples were fixed with 10% formalin and embedded in paraffin. Then, the tissues were cut transversely into 5&#xa0;&#xb5;m-thick sections, deparaffinized, rehydrated, and subjected to antigen retrieval. For immunofluorescence staining, the slices were incubated with primary antibodies overnight at 4&#xb0;C, and then incubated with secondary antibodies for 2&#xa0;h at room temperature. The following primary antibodies were used: goat anti-CCR7 (1:200; Novus Biologicals, Littleton, CO), rabbit anti-GPR174 (1:200; Biorbyt, Cambridge, United Kingdom), mouse anti-&#x3b1;-Actinin (1:250; Santa Cruz Technology, CA), and mouse anti-Vimentin (1:200; Abcam, CA). The nuclei were counterstained with DAPI. At least four random and nonoverlapping of views in areas surrounding the infarct area in the I/R group or the corresponding area in the sham group were observed using the fluorescence microscope. Images were analyzed using the Image Pro Plus software.</p>
</sec>
<sec id="s2-15">
<title>Statistical analysis</title>
<p>Statistical analysis was performed by using the GraphPad Prism software (version 9.0, GraphPad, San Diego, CA). Data were expressed as mean &#xb1; standard error of the mean and compared using <italic>t</italic>-test. A two-tailed value of <italic>p</italic> &#x3c; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Identification of differentially expressed genes during myocardial I/R injury</title>
<p>The expression profiles of 12,549 genes in GSE6381 of human right ventricular samples during myocardial I/R process were analyzed. The DEGs were identified in three comparisons (<xref ref-type="fig" rid="F1">Figure 1A</xref>): 309 DEGs (247 upregulated and 62 downregulated) in end-ischemia vs. cardiac arrest (<xref ref-type="sec" rid="s11">Supplementary Table S1</xref>), 175 DEGs (90 upregulated and 85 downregulated) in reperfusion vs. end-ischemia (<xref ref-type="sec" rid="s11">Supplementary Table S2</xref>), and 217 DEGs (165 up-regulated and 52 down-regulated) in reperfusion vs. cardiac arrest (<xref ref-type="sec" rid="s11">Supplementary Table S3</xref>). These DEGs showed apparently differential expression profiles (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The top 10 up- and downregulated DEGs for each comparison are presented in <xref ref-type="table" rid="T2">Table 2</xref>. There were 40, 34, and 51 common DEGs between two comparisons, but no gene was found as common to the three (<xref ref-type="fig" rid="F1">Figure 1C</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S4</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Identification of DEGs. <bold>(A)</bold> Volcano plots and pie charts showing DEGs for end-ischemia vs. cardiac arrest, reperfusion vs. end-ischemia, and reperfusion vs. cardiac arrest. <bold>(B)</bold> Heatmaps of DEGs. <bold>(C)</bold> Venn&#x2019;s diagram showing common DEGs among comparisons.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g001.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Top 10 upregulated and downregulated DEGs for each comparison.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left">Upregulated</th>
<th align="left">log2FC</th>
<th align="left">p-value</th>
<th align="left">Downregulated</th>
<th align="left">log2FC</th>
<th align="left">p-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="10" align="left">End-ischemia vs. cardiac arrest</td>
<td align="left">CUX2</td>
<td align="char" char=".">3.336828</td>
<td align="char" char=".">1.25E-06</td>
<td align="left">C3orf36</td>
<td align="char" char=".">&#x2212;2.3478</td>
<td align="left">0.000816</td>
</tr>
<tr>
<td align="left">TPH1</td>
<td align="char" char=".">3.265775</td>
<td align="char" char=".">0.001979</td>
<td align="left">SUSD5</td>
<td align="char" char=".">&#x2212;2.02744</td>
<td align="left">0.001272</td>
</tr>
<tr>
<td align="left">KPNA5</td>
<td align="char" char=".">2.703</td>
<td align="char" char=".">0.010906</td>
<td align="left">SLC15A3</td>
<td align="char" char=".">&#x2212;1.93057</td>
<td align="left">3.68E-06</td>
</tr>
<tr>
<td align="left">KIF23</td>
<td align="char" char=".">2.593434</td>
<td align="char" char=".">0.007537</td>
<td align="left">FBXL15</td>
<td align="char" char=".">&#x2212;1.8243</td>
<td align="left">0.012578</td>
</tr>
<tr>
<td align="left">FCGR1A</td>
<td align="char" char=".">2.45906</td>
<td align="char" char=".">0.000147</td>
<td align="left">ST6GAL1</td>
<td align="char" char=".">&#x2212;1.76525</td>
<td align="left">0.005889</td>
</tr>
<tr>
<td align="left">KRT5</td>
<td align="char" char=".">2.301802</td>
<td align="char" char=".">0.000472</td>
<td align="left">EPHX2</td>
<td align="char" char=".">&#x2212;1.75484</td>
<td align="left">0.014952</td>
</tr>
<tr>
<td align="left">GABRA6</td>
<td align="char" char=".">2.264973</td>
<td align="char" char=".">0.024899</td>
<td align="left">ENTPD7</td>
<td align="char" char=".">&#x2212;1.74397</td>
<td align="left">0.000172</td>
</tr>
<tr>
<td align="left">TEX12</td>
<td align="char" char=".">2.246953</td>
<td align="char" char=".">0.001967</td>
<td align="left">PARP11</td>
<td align="char" char=".">&#x2212;1.72645</td>
<td align="left">0.01515</td>
</tr>
<tr>
<td align="left">MDM4</td>
<td align="char" char=".">2.198717</td>
<td align="char" char=".">0.004825</td>
<td align="left">UBIAD1</td>
<td align="char" char=".">&#x2212;1.7032</td>
<td align="left">6.85E-05</td>
</tr>
<tr>
<td align="left">NPY1R</td>
<td align="char" char=".">2.175747</td>
<td align="char" char=".">0.002343</td>
<td align="left">VASH2</td>
<td align="char" char=".">&#x2212;1.62708</td>
<td align="left">0.037364</td>
</tr>
<tr>
<td rowspan="10" align="left">Reperfusion vs. end-ischemia</td>
<td align="left">THAP9</td>
<td align="char" char=".">2.392984</td>
<td align="char" char=".">0.000677</td>
<td align="left">SPICE1</td>
<td align="char" char=".">&#x2212;2.86651</td>
<td align="left">7.54E-05</td>
</tr>
<tr>
<td align="left">KLF3-AS1</td>
<td align="char" char=".">2.31404</td>
<td align="char" char=".">1.45E-05</td>
<td align="left">MDM4</td>
<td align="char" char=".">&#x2212;2.17014</td>
<td align="left">5.58E-05</td>
</tr>
<tr>
<td align="left">BARD1</td>
<td align="char" char=".">2.143729</td>
<td align="char" char=".">0.003722</td>
<td align="left">RAG1</td>
<td align="char" char=".">&#x2212;2.14513</td>
<td align="left">0.000531</td>
</tr>
<tr>
<td align="left">NEUROD1</td>
<td align="char" char=".">2.117173</td>
<td align="char" char=".">0.025112</td>
<td align="left">SPANXB1</td>
<td align="char" char=".">&#x2212;2.13357</td>
<td align="left">0.025505</td>
</tr>
<tr>
<td align="left">ZNF124</td>
<td align="char" char=".">2.0379</td>
<td align="char" char=".">0.003054</td>
<td align="left">SPATA1</td>
<td align="char" char=".">&#x2212;2.00897</td>
<td align="left">0.027544</td>
</tr>
<tr>
<td align="left">SLC5A12</td>
<td align="char" char=".">1.968573</td>
<td align="char" char=".">0.008834</td>
<td align="left">GABRA6</td>
<td align="char" char=".">&#x2212;1.98757</td>
<td align="left">0.035172</td>
</tr>
<tr>
<td align="left">BMPR1B</td>
<td align="char" char=".">1.967616</td>
<td align="char" char=".">0.002339</td>
<td align="left">SRY</td>
<td align="char" char=".">&#x2212;1.9426</td>
<td align="left">0.004901</td>
</tr>
<tr>
<td align="left">CDIP1</td>
<td align="char" char=".">1.92239</td>
<td align="char" char=".">0.01451</td>
<td align="left">TRHDE</td>
<td align="char" char=".">&#x2212;1.91529</td>
<td align="left">0.04149</td>
</tr>
<tr>
<td align="left">MATN3</td>
<td align="char" char=".">1.919535</td>
<td align="char" char=".">0.018881</td>
<td align="left">MMP17</td>
<td align="char" char=".">&#x2212;1.86525</td>
<td align="left">0.000624</td>
</tr>
<tr>
<td align="left">MNX1</td>
<td align="char" char=".">1.832299</td>
<td align="char" char=".">0.012009</td>
<td align="left">LOC389906</td>
<td align="char" char=".">&#x2212;1.8647</td>
<td align="left">0.000316</td>
</tr>
<tr>
<td rowspan="10" align="left">Reperfusion vs. cardiac arrest</td>
<td align="left">KPNA5</td>
<td align="char" char=".">3.054913</td>
<td align="char" char=".">0.010476</td>
<td align="left">ZNF667</td>
<td align="char" char=".">&#x2212;1.87117</td>
<td align="left">0.005366</td>
</tr>
<tr>
<td align="left">CUX2</td>
<td align="char" char=".">2.981681</td>
<td align="char" char=".">4.32E-06</td>
<td align="left">NPL</td>
<td align="char" char=".">&#x2212;1.81029</td>
<td align="left">1.62E-06</td>
</tr>
<tr>
<td align="left">THAP9</td>
<td align="char" char=".">2.600435</td>
<td align="char" char=".">0.001636</td>
<td align="left">SSSCA1</td>
<td align="char" char=".">&#x2212;1.79372</td>
<td align="left">0.005242</td>
</tr>
<tr>
<td align="left">JPH3</td>
<td align="char" char=".">2.232684</td>
<td align="char" char=".">0.003121</td>
<td align="left">GSR</td>
<td align="char" char=".">&#x2212;1.7579</td>
<td align="left">0.014834</td>
</tr>
<tr>
<td align="left">CSN1S1</td>
<td align="char" char=".">2.225056</td>
<td align="char" char=".">0.015934</td>
<td align="left">GTF3C5</td>
<td align="char" char=".">&#x2212;1.73627</td>
<td align="left">0.008104</td>
</tr>
<tr>
<td align="left">SLC5A12</td>
<td align="char" char=".">2.203091</td>
<td align="char" char=".">0.01966</td>
<td align="left">CTB-176F20.3</td>
<td align="char" char=".">&#x2212;1.67732</td>
<td align="left">0.008956</td>
</tr>
<tr>
<td align="left">TRPM6</td>
<td align="char" char=".">2.184206</td>
<td align="char" char=".">0.000506</td>
<td align="left">LTBR</td>
<td align="char" char=".">&#x2212;1.66943</td>
<td align="left">0.005418</td>
</tr>
<tr>
<td align="left">MBL2</td>
<td align="char" char=".">2.170036</td>
<td align="char" char=".">0.01262</td>
<td align="left">RAG1</td>
<td align="char" char=".">&#x2212;1.62025</td>
<td align="left">0.003965</td>
</tr>
<tr>
<td align="left">CCDC81</td>
<td align="char" char=".">2.128599</td>
<td align="char" char=".">0.003659</td>
<td align="left">BTF3P11</td>
<td align="char" char=".">&#x2212;1.61682</td>
<td align="left">0.017243</td>
</tr>
<tr>
<td align="left">MTNR1A</td>
<td align="char" char=".">2.10746</td>
<td align="char" char=".">0.013072</td>
<td align="left">EMILIN2</td>
<td align="char" char=".">&#x2212;1.54244</td>
<td align="left">0.009152</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>DEG, differentially expressed gene; FC, fold change.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Pathway and process enrichment analyses of differentially expressed genes revealed significantly enriched terms</title>
<p>The pathway and process enrichment analyses of DEGs for each comparison were conducted by using the Metascape. <xref ref-type="fig" rid="F2">Figure 2A</xref> shows gene overlaps and genes that belong to the same enriched ontology term. The top 20 enriched terms are colored by <italic>p</italic>-values in the heatmap (<xref ref-type="fig" rid="F2">Figure 2B</xref>), with the characteristics shown in <xref ref-type="fig" rid="F2">Figure 2C</xref>. Of these, inorganic ion homeostasis, positive regulation of JNK cascade, and cytokine-mediated signaling pathway may be closely related to the myocardial I/R process. Neuroactive ligand-receptor interaction is the common KEGG pathway. The top 100 enriched terms are available in <xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>. Furthermore, the relationships of the significantly enriched terms are visualized in networks, colored by cluster IDs (<xref ref-type="fig" rid="F2">Figure 2D</xref>), <italic>p</italic>-values (<xref ref-type="fig" rid="F2">Figure 2E</xref>), and gene list identities (<xref ref-type="fig" rid="F2">Figure 2F</xref>). All results of the enrichment analyses are listed in <xref ref-type="sec" rid="s11">Supplementary Table S5</xref>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Functional enrichment analyses of DEGs. <bold>(A)</bold> Circos plot showing gene overlaps and genes of the same enriched ontology term. Purple curves link common genes, and blue curves link genes belonging to the same enriched term. Dark orange indicates genes that hit multiple lists, and light orange indicates genes unique to a list. <bold>(B)</bold> Heatmap showing top 20 enriched terms, colored by <italic>p</italic>-values. <bold>(C)</bold> Characteristics of top 20 enriched terms. Count (%) indicates the number (percentage) of genes in the given ontology term. <bold>(D)</bold> Networks colored by cluster IDs, where nodes with the same ID are close to each other. <bold>(E)</bold> Networks colored by <italic>p</italic>-values. <bold>(F)</bold> Networks with pie charts, color-coded by identities of the genes.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Protein&#x2013;protein interaction analyses of differentially expressed genes revealed key modules and hub proteins</title>
<p>The PPI networks of DEGs were performed to identify key modules with highly clustered proteins using the MCODE functionality. All interactions of the proteins are presented in <xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>. The PPI analyses revealed a total of 10 key modules. The MCODE one contained 26 highly clustered proteins: C5AR1, CASR, CCL21, CHRM4, CNR1, CORT, CXCL13, EDN1, EDN3, GNRH2, GNRHR, GRM8, HCRTR1, HCRTR2, MTNR1A, NMBR, NPY1R, NTS, NTSR1, OPRD1, OPRK1, P2RY10, P2RY6, PPY, TACR3, and XCR1. In the MCODE networks, the interactions among the 26 hub proteins were colored by MCODE cluster IDs (<xref ref-type="fig" rid="F3">Figure 3A</xref>) and identities of the proteins (<xref ref-type="fig" rid="F3">Figure 3B</xref>). The annotations of the 26 genes are presented in <xref ref-type="table" rid="T3">Table 3</xref>.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Key candidate genes and PPI network analysis. <bold>(A)</bold> Interactions among hub proteins in MCODE cluster 1. <bold>(B)</bold> Interactions among hub proteins, colored by identities of the proteins. <bold>(C)</bold> Top 10 enriched BP, CC, and MF terms, and enriched KEGG pathway. <bold>(D)</bold> Protein-protein interaction networks and functions.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g003.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Annotation of 26 key genes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene</th>
<th align="left">Gene ID</th>
<th align="left">Species</th>
<th align="left">Description</th>
<th align="left">Gene location</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<italic>C5AR1</italic>
</td>
<td align="left">728</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">complement C5a receptor 1</td>
<td align="left">chr19:47309861-47322065</td>
</tr>
<tr>
<td align="left">
<italic>CASR</italic>
</td>
<td align="left">846</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">calcium sensing receptor</td>
<td align="left">chr3:122183668-122291628</td>
</tr>
<tr>
<td align="left">
<italic>CCL21</italic>
</td>
<td align="left">6366</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">C-C motif chemokine ligand 21</td>
<td align="left">chr9:34709005-34710136</td>
</tr>
<tr>
<td align="left">
<italic>CHRM4</italic>
</td>
<td align="left">1132</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">cholinergic receptor muscarinic 4</td>
<td align="left">chr11:46383791-46391614</td>
</tr>
<tr>
<td align="left">
<italic>CNR1</italic>
</td>
<td align="left">1268</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">cannabinoid receptor 1</td>
<td align="left">chr6:88139866-88163023</td>
</tr>
<tr>
<td align="left">
<italic>CORT</italic>
</td>
<td align="left">1325</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">cortistatin</td>
<td align="left">chr1:10450031-10451998</td>
</tr>
<tr>
<td align="left">
<italic>CXCL13</italic>
</td>
<td align="left">10,563</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">C-X-C motif chemokine ligand 13</td>
<td align="left">chr4:77511753-77611836</td>
</tr>
<tr>
<td align="left">
<italic>EDN1</italic>
</td>
<td align="left">1906</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">endothelin 1</td>
<td align="left">chr6:12290361-12297194</td>
</tr>
<tr>
<td align="left">
<italic>EDN3</italic>
</td>
<td align="left">1908</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">endothelin 3</td>
<td align="left">chr20:59300611-59325992</td>
</tr>
<tr>
<td align="left">
<italic>GNRH2</italic>
</td>
<td align="left">2797</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">gonadotropin releasing hormone 2</td>
<td align="left">chr20:3043622-3045747</td>
</tr>
<tr>
<td align="left">
<italic>GNRHR</italic>
</td>
<td align="left">2798</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">gonadotropin releasing hormone receptor</td>
<td align="left">chr4:67737381-67756086</td>
</tr>
<tr>
<td align="left">
<italic>GRM8</italic>
</td>
<td align="left">2918</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">glutamate metabotropic receptor 8</td>
<td align="left">chr7:126438598-127243515</td>
</tr>
<tr>
<td align="left">
<italic>HCRTR1</italic>
</td>
<td align="left">3061</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">hypocretin receptor 1</td>
<td align="left">chr1:31617700-31627318</td>
</tr>
<tr>
<td align="left">
<italic>HCRTR2</italic>
</td>
<td align="left">3062</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">hypocretin receptor 2</td>
<td align="left">chr6:55106460-55282741</td>
</tr>
<tr>
<td align="left">
<italic>MTNR1A</italic>
</td>
<td align="left">4543</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">melatonin receptor 1A</td>
<td align="left">chr4:186533655-186555567</td>
</tr>
<tr>
<td align="left">
<italic>NMBR</italic>
</td>
<td align="left">4829</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">neuromedin B receptor</td>
<td align="left">chr6:142074484-142088799</td>
</tr>
<tr>
<td align="left">
<italic>NPY1R</italic>
</td>
<td align="left">4886</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">neuropeptide Y receptor Y1</td>
<td align="left">chr4:163323962-163332596</td>
</tr>
<tr>
<td align="left">
<italic>NTS</italic>
</td>
<td align="left">4922</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">neurotensin</td>
<td align="left">chr12:85874295-85882992</td>
</tr>
<tr>
<td align="left">
<italic>NTSR1</italic>
</td>
<td align="left">4923</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">neurotensin receptor 1</td>
<td align="left">chr20:62708836-62762771</td>
</tr>
<tr>
<td align="left">
<italic>OPRD1</italic>
</td>
<td align="left">4985</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">opioid receptor delta 1</td>
<td align="left">chr1:28812170-28871267</td>
</tr>
<tr>
<td align="left">
<italic>OPRK1</italic>
</td>
<td align="left">4986</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">opioid receptor kappa 1</td>
<td align="left">chr8:53225724-53251637</td>
</tr>
<tr>
<td align="left">
<italic>P2RY10</italic>
</td>
<td align="left">27334</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">P2Y receptor family member 10</td>
<td align="left">chrX:78945391-78963727</td>
</tr>
<tr>
<td align="left">
<italic>P2RY6</italic>
</td>
<td align="left">5031</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">pyrimidinergic receptor P2Y6</td>
<td align="left">chr11:73264505-73298625</td>
</tr>
<tr>
<td align="left">
<italic>PPY</italic>
</td>
<td align="left">5539</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">pancreatic polypeptide</td>
<td align="left">chr17:43940804-43942476</td>
</tr>
<tr>
<td align="left">
<italic>TACR3</italic>
</td>
<td align="left">6870</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">tachykinin receptor 3</td>
<td align="left">chr4:103586033-103719985</td>
</tr>
<tr>
<td align="left">
<italic>XCR1</italic>
</td>
<td align="left">2829</td>
<td align="left">
<italic>H. sapiens</italic>
</td>
<td align="left">X-C motif chemokine receptor 1</td>
<td align="left">chr3:46017009-46027483</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-4">
<title>Identification of key candidate genes related to calcium homeostasis and regulation</title>
<p>Based on the 26 genes, GO and KEGG enrichment analyses were performed using the gProfiler. Of the top significantly enriched BP, CC, and MF terms, cellular calcium ion homeostasis (GO:0006874) and calcium ion homeostasis (GO:0055074) were noted in the process of myocardial I/R injury (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Thirteen genes were involved, including <italic>P2RY10</italic>, <italic>HCRTR1</italic>, <italic>HCRTR2</italic>, <italic>NTSR1</italic>, <italic>CASR</italic>, <italic>XCR1</italic>, <italic>P2RY6</italic>, <italic>EDN3</italic>, <italic>EDN1</italic>, <italic>CNR1</italic>, <italic>CCL21</italic>, <italic>C5AR1</italic>, and <italic>CXCL13</italic>. In addition, KEGG analysis showed one enriched pathway, neuroactive ligand-receptor interaction (<xref ref-type="fig" rid="F3">Figure 3C</xref>), in line with the previous results (<xref ref-type="fig" rid="F2">Figure 2C</xref>). All enrichment results are available in <xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S6</xref>.</p>
<p>To further reveal the interactions of the 26 hub proteins, PPI network and functional analysis were conducted using the GeneMANIA (<xref ref-type="fig" rid="F3">Figure 3D</xref>). There were substantial and complex relationships within these proteins, including co-expressions, physical interactions, shared protein domains, pathways, predicted interactions, co-localizations, and genetic interactions (<xref ref-type="sec" rid="s11">Supplementary Table S7</xref>). In addition, the functional analysis revealed several gene functions (<xref ref-type="sec" rid="s11">Supplementary Table S8</xref>). Of note, there were three functions of calcium regulation (cellular calcium ion homeostasis, calcium ion homeostasis, and positive regulation of cytosolic calcium ion concentration). In these calcium-related functions, five hub proteins (CCL21, XCR1, CXCL13, EDN1, and CASR) were revealed, which were significantly enriched in two calcium processes (<xref ref-type="fig" rid="F3">Figure 3C</xref>).</p>
</sec>
<sec id="s3-5">
<title>Gene set enrichment analysis of ischemia and reperfusion samples revealed significantly enriched pathways</title>
<p>Based on the ischemia samples, GSEA revealed several significantly enriched pathways, including neuroactive ligand receptor interaction, GNRH signaling pathway, calcium signaling pathway, WNT signaling pathway, VEGF signaling pathway, and JAK-STAT signaling pathway (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Based on the reperfusion samples, GSEA revealed several significantly enriched pathways, including neuroactive ligand receptor interaction, VEGF signaling pathway, JAK-STAT signaling pathway, and WNT signaling pathway (<xref ref-type="fig" rid="F4">Figure 4B</xref>). All results of GSEA enriched pathways are available in <xref ref-type="sec" rid="s11">Supplementary Tables S9, S10</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Gene set enrichment analysis of the ischemia and reperfusion samples. <bold>(A)</bold> Enriched pathways in ischemia samples. <bold>(B)</bold> Enriched pathways in reperfusion samples.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g004.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Pathological changes and apoptosis in myocardial I/R injury</title>
<p>Compared to the sham controls, myocardial I/R injury led to an obvious myocardial infract size (approximately 40%) in the Evans blue/TTC staining (<xref ref-type="fig" rid="F5">Figure 5A</xref>). In addition, HE staining showed remarkable myocardial histological damage following myocardial I/R injury (<xref ref-type="fig" rid="F5">Figure 5B</xref>). The structure of myocardial tissue in the sham group was clear and aligned, with intact myocardial fibers; however, the I/R group showed a damaged tissue structure, swollen cardiomyocytes, disarranged myofibrils, and leukocytes infiltration. The TUNEL assay was performed to assess the level of DNA fragmentation in myocardial apoptotic cells. The results showed a significantly increased TUNEL apoptosis rate induced by myocardial I/R injury (<xref ref-type="fig" rid="F5">Figure 5C</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Myocardial I/R injury in mice. <bold>(A)</bold> Evans blue/TTC staining showing myocardial infract size in the sham and I/R groups. <bold>(B)</bold> HE staining showing myocardial histological damage. Scale bar &#x3d; 100&#xa0;&#x3bc;m (left) and 50&#xa0;&#x3bc;m (right). <bold>(C)</bold> TUNEL staining showing the apoptosis rate in the myocardium. Scale bar &#x3d; 100&#xa0;&#x3bc;m <italic>n</italic> &#x3d; 3. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 vs. the sham group. I/R, ischemia reperfusion; AAR, area at risk; IA, infarct area; LV, left ventricle.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g005.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>Validation of mRNA and protein expression of key genes and related receptors</title>
<p>Based on the PPI network and hub protein analyses, five key genes (<italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, <italic>EDN1</italic>, and <italic>CASR</italic>) were identified. To investigate the role of these genes at the early stage of myocardial I/R injury, the mRNA expression of these genes was determined using the qPCR. The results showed that the mRNA expression of <italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, and <italic>CASR</italic> were significantly up-regulated in the left ventricular samples of myocardial I/R injury (<xref ref-type="fig" rid="F6">Figure 6A</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>mRNA and protein expression of key genes and related receptors. <bold>(A)</bold> mRNA expression of CCL21, XCR1, CXCL13, CASR, and EDN1. <bold>(B)</bold> Protein expression of CCL21, CXCL13, and XCR1. <bold>(C)</bold> Protein expression of GPR174/CCR7 (the receptors of CCL21) and CXCR5 (the receptors of CXCL13). <italic>n</italic> &#x3d; 3&#x2013;6. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 vs. the sham group. I/R, ischemia reperfusion.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g006.tif"/>
</fig>
<p>Given that chemokines are small secreted proteins with chemoattractant properties that play a key role in inflammation and cell apoptosis (<xref ref-type="bibr" rid="B15">Jarrah et al., 2018</xref>; <xref ref-type="bibr" rid="B42">Zhang et al., 2020</xref>), we assessed the protein expression of CCL21, XCR1, and CXCL13. The results showed that the protein expression of CCL21 and CXCL13 was significantly increased following myocardial I/R injury (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Next, we tested the protein expression of GPR174 and CCR7 (known receptors of CCL21) (<xref ref-type="bibr" rid="B6">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="B35">Van Raemdonck et al., 2020</xref>; <xref ref-type="bibr" rid="B43">Zhao et al., 2020</xref>) and CXCR5 (a known receptor of CXCL13) (<xref ref-type="bibr" rid="B14">Hussain et al., 2019</xref>; <xref ref-type="bibr" rid="B29">Shen et al., 2020</xref>). We found that the protein expression of GPR174 and CCR7, but not CXCR5, was significantly elevated. These results suggested that the CCL21-GPR174/CCR7 chemokine axis was involved in the early stage of myocardial I/R injury (<xref ref-type="fig" rid="F6">Figure 6C</xref>).</p>
</sec>
<sec id="s3-8">
<title>Activation of GPR174/CCR7 on cardiac fibroblasts in myocardial I/R injury</title>
<p>We detected the expression and cellular localization of GPR174 and CCR7 using the immunofluorescence staining. The double-labeling immunofluorescence results showed that there was no GPR174 positive cells (green) co-localized with the &#x3b1;-Actinin positive cells (red) in the sham or myocardial I/R mice, suggesting that GPR174 did not present on cardiomyocytes (<xref ref-type="fig" rid="F7">Figure 7A</xref>). Therefore, we further investigated whether GPR174 was expressed in the cardiac fibroblasts. Following myocardial I/R injury, GPR174 positive cells (green) and Vimentin positive cells (red) co-localized in the left ventricular myocardial tissues, and the expression of GPR174 on cardiac fibroblasts was significantly increased (<xref ref-type="fig" rid="F7">Figure 7B</xref>). Similarly, we also found that myocardial I/R-induced activation of CCR7 was also evident on cardiac fibroblasts (<xref ref-type="fig" rid="F7">Figure 7C</xref>). Taken together, these results suggested that the up-regulated GPR174 and CCR7 on the cardiac fibroblasts underlie the pathological course of myocardial I/R injury.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Expression of GPR174 and CCR7 on cardiac fibroblasts during myocardial I/R injury. <bold>(A)</bold> Immunofluorescence staining showing that GPR174 did not present on cardiomyocytes in the sham or I/R groups. <bold>(B)</bold> Immunofluorescence staining showing the expression of GPR174 on cardiac fibroblasts. <bold>(C)</bold> Immunofluorescence staining showing the expression of CCR7 on cardiac fibroblasts in the sham and I/R groups. Scale bar &#x3d; 50&#xa0;&#x3bc;m <italic>n</italic> &#x3d; 3. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 vs. the sham group. I/R, ischemia reperfusion.</p>
</caption>
<graphic xlink:href="fgene-13-946524-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study, the gene expression profiles of human right ventricular samples during myocardial I/R process in cardiac surgery was explored with the use of a comprehensive bioinformatics approach. We identified 309 DEGs for end-ischemia vs. cardiac arrest, 175 DEGs for reperfusion vs. end-ischemia, and 217 DEGs for reperfusion vs. cardiac arrest. Based on pathway and process enrichment analyses, PPI analysis, and MCODE assay, several key modules with hub proteins were revealed. Further enrichment and network analyses of the highly clustered proteins highlighted five key candidate genes (<italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, <italic>EDN1</italic>, and <italic>CASR</italic>) related to calcium homeostasis and regulation. In addition, GSEA confirmed several significantly enriched pathways in the ischemia and reperfusion stages. Next, we performed the validation experiments in animal studies using qPCR and Western blots. The results confirmed that the mRNA and protein expression of CCL21 and CXCL13 were elevated during myocardial I/R injury in mice. Furthermore, myocardial I/R injury induced the activation of GPR174/CCR7 (the CCL21 receptors), but not CXCR5 (the CXCL13 receptor). Notably, the increased expression of GPR174/CCR7 was located within cardiac fibroblasts.</p>
<p>The major difference between our study and the previous one (<xref ref-type="bibr" rid="B1">Arab et al., 2007</xref>) is the discovery of novel key candidate genes associated with calcium signaling pathway during the myocardial I/R process in cardiac surgery. Of note, these key genes (<italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, <italic>EDN1</italic>, and <italic>CASR</italic>) were significantly enriched in the processes of calcium homeostasis and regulation, including cellular calcium ion homeostasis, calcium ion homeostasis, and positive regulation of cytosolic calcium ion concentration. Given that intracellular calcium overload is a critical mechanism for cardiomyocyte apoptosis and cell death during myocardial I/R injury (<xref ref-type="bibr" rid="B8">Garcia-Dorado et al., 2012</xref>; <xref ref-type="bibr" rid="B20">Mattiazzi et al., 2015</xref>), the identification of these novel genes may provide a new preventive and therapeutic basis for intraoperative cardioprotection.</p>
<p>Of these five genes, <italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, and <italic>EDN1</italic> have yet to be evaluated in the context of myocardial I/R injury. CCL21, chemokine (C-C motif) ligand 21, is a small cytokine belonging to the CC chemokine family. A previous study showed that CCL21 was responsible for ischemic brain damage, while CD93 mediated neuroprotection <italic>via</italic> suppressing neuroinflammation through downregulation of CCL21 (<xref ref-type="bibr" rid="B10">Harhausen et al., 2010</xref>). XCR1, X-C motif chemokine receptor 1, is a chemokine receptor belonging to the G protein-coupled receptor superfamily, which induces calcium mobilization (<xref ref-type="bibr" rid="B39">Yoshida et al., 1998</xref>). CXCL13, chemokine (C-X-C motif) ligand 13, has recently been found to play an important role in spinal cord I/R injury (<xref ref-type="bibr" rid="B5">Chen et al., 2019</xref>). Specifically, knockdown of CXCL13 by small interfering RNA protected the rats against spinal cord I/R injury <italic>via</italic> suppressing the activity of relevant signaling pathways and proinflammatory cytokines (<xref ref-type="bibr" rid="B5">Chen et al., 2019</xref>). EDN1, endothelin-1, is a potent vasoconstrictor produced by vascular endothelial cells. In a porcine liver transplant mode, improved viability of damaged liver grafts by oxygenated hypothermic machine perfusion was associated with a reduced EDN1 expression (<xref ref-type="bibr" rid="B36">Vekemans et al., 2011</xref>). CASR, a calcium-sensing receptor, has been investigated in myocardial I/R injury in recent studies, suggesting that inhibition of CASR attenuated myocardial I/R injury through suppressing endoplasmic reticulum stress-associated apoptotic signaling pathways (<xref ref-type="bibr" rid="B33">Sun et al., 2017</xref>; <xref ref-type="bibr" rid="B19">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="B38">Yin et al., 2019</xref>).</p>
<p>According to the GSEA results, several calcium-related KEGG pathways were significantly enriched in the human right ventricular samples during the ischemia and reperfusion stages, including calcium signaling pathway, GNRH signaling pathway, WNT signaling pathway, VEGF signaling pathway, and JAK-STAT signaling pathway. These findings suggest their important contribution to the cellular calcium homeostasis and regulation in the myocardial I/R process. It has been highlighted that disorder of calcium homeostasis is a pivotal mechanism underlying myocardial I/R injury (<xref ref-type="bibr" rid="B8">Garcia-Dorado et al., 2012</xref>; <xref ref-type="bibr" rid="B20">Mattiazzi et al., 2015</xref>; <xref ref-type="bibr" rid="B16">Kristiansen et al., 2017</xref>). Our recent study also showed that H9c2 cardiomyocytes exposed to oxygen-glucose deprivation/reoxygenation had decreased cell viability, elevated intracellular calcium levels, changes in calcium-related signaling activity, and increased cell apoptosis, which was alleviated by pretreatment with dexmedetomidine, a selective &#x3b1;2-adrenoceptor agonist offering protective effects against I/R injury (<xref ref-type="bibr" rid="B40">Yuan et al., 2019</xref>).</p>
<p>Until recently, the relation between CCR7 and cardiac fibroblasts in context of myocardial injury has not been well elucidated. A previous study suggested the redistribution of chemokine receptor CCR7 from peripheral blood to the infarcted heart during myocardial I/R following primary percutaneous coronary intervention procedures (<xref ref-type="bibr" rid="B13">Hoffmann et al., 2012</xref>). Another study suggested that CCL21/CCR7 interactions was involved in left ventricular remodeling during pressure overload in patients with aortic stenosis (<xref ref-type="bibr" rid="B7">Finsen et al., 2014</xref>). Based on the existing literature, we assume that CCR7 might migrate from peripheral blood to cardiac fibroblasts with an interaction of CCL21, which plays a role in the etiology of myocardial I/R injury.</p>
<p>This study has several limitations. First, the bioinformatic analyses were based on a relatively small number of human ventricular samples from a single microarray data. An integrated analysis of several datasets might have provided more information and insight. Second, the GEO dataset (GSE6381) and ensuring animal studies were based on different species and different parts of heart: right ventricular of human from the GEO dataset, and left ventricular of mice from the animal studies. Although we performed the qPCR, western blots, and immunofluorescence staining experiments to validate the expression of the key genes, the myocardial I/R injury model in mice was different from the human heart samples during cardiac surgery. Hence, the differences in methodology and species should be taken into consideration when interpreting these data, and more studies are still needed to collaborate our findings. Third, the expression profiles of myocardium during intraoperative myocardial I/R obtained in this study was only on the gene level, without assessment and relationships of non-coding RNAs, such as micro RNAs, circular RNAs, or long non-coding RNAs. Last, we showed that myocardial I/R injury increased the expression of CCL21, along with the activation of GPR174/CCR7 within cardiac fibroblasts, but further functional experiments are still needed for mechanistic explorations.</p>
<p>In conclusion, the present study revealed five key genes (<italic>CCL21</italic>, <italic>XCR1</italic>, <italic>CXCL13</italic>, <italic>EDN1</italic>, and <italic>CASR</italic>) and calcium homeostasis and regulation pathways during myocardial I/R injury. The expression of CCL21 and CXCL13 were validated in myocardial I/R injury of mice. We highlighted the increased expression of CCL21 with the activation of receptors GPR174/CCR7 on cardiac fibroblasts underlying myocardial I/R injury. Our findings may provide insights into development of preventive and therapeutic targets for intraoperative cardioprotection.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the Jianguoyun/Nutstore repository, available at: <ext-link ext-link-type="uri" xlink:href="https://www.jianguoyun.com/p/Dd2OkgkQxvzPChiIpcMEIAA">https://www.jianguoyun.com/p/Dd2OkgkQxvzPChiIpcMEIAA</ext-link>.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Ethic Committee for Animal Care and Use of Soochow University.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>All authors made substantial contributions to the design of this study, data acquisition and interpretation, statistical plan, drafting the manuscript, or revising the manuscript critically. All authors agreed to be accountable for all aspects of the work and gave their final approval of this version to be published.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This study was supported by National Natural Science Foundation of China (82072130 and 81873925), Natural Science Foundation of Jiangsu Province (BK20191171), Jiangsu Government Scholarship for Overseas Studies (JS-2018-178), 333 High-level Talent Training Project in Jiangsu Province (BRA2020089), and Six Talent Peaks Project in Jiangsu Province (WSN-022).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.946524/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2022.946524/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table2.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.xlsx" id="SM2" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table9.xlsx" id="SM3" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image3.TIF" id="SM4" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image2.TIF" id="SM5" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table6.xlsx" id="SM6" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table4.xlsx" id="SM7" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.xlsx" id="SM8" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.PNG" id="SM9" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table10.xlsx" id="SM10" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table5.xlsx" id="SM11" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table7.xlsx" id="SM12" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table8.xlsx" id="SM13" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arab</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Konstantinov</surname>
<given-names>I. E.</given-names>
</name>
<name>
<surname>Boscarino</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cukerman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery</article-title>. <source>J. Thorac. Cardiovasc. Surg.</source> <volume>134</volume> (<issue>74-81</issue>), <fpage>74</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2007.01.025</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bader</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Hogue</surname>
<given-names>C. W.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>An automated method for finding molecular complexes in large protein interaction networks</article-title>. <source>BMC Bioinforma.</source> <volume>4</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-4-2</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boag</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shmeleva</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Bagnall</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Egred</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients</article-title>. <source>J. Clin. Invest.</source> <volume>125</volume>, <fpage>3063</fpage>&#x2013;<lpage>3076</lpage>. <pub-id pub-id-type="doi">10.1172/JCI80055</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulluck</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yellon</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Hausenloy</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Reducing myocardial infarct size: Challenges and future opportunities</article-title>. <source>Heart</source> <volume>102</volume>, <fpage>341</fpage>&#x2013;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-307855</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The roles of chemokine (C-X-C motif) ligand 13 in spinal cord ischemia-reperfusion injury in rats</article-title>. <source>Brain Res.</source> <volume>1727</volume>, <fpage>146489</fpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2019.146489</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway</article-title>. <source>J. Cell. Physiol.</source> <volume>235</volume>, <fpage>5995</fpage>&#x2013;<lpage>6009</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.29525</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finsen</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Ueland</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sjaastad</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ranheim</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Dahl</surname>
<given-names>C. P.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e112172</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112172</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Dorado</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ruiz-Meana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Inserte</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodriguez-Sinovas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Piper</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Calcium-mediated cell death during myocardial reperfusion</article-title>. <source>Cardiovasc. Res.</source> <volume>94</volume>, <fpage>168</fpage>&#x2013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvs116</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>miR-181c-5p exacerbates hypoxia/reoxygenation-induced cardiomyocyte apoptosis via targeting PTPN4</article-title>. <source>Oxid. Med. Cell. Longev.</source> <volume>2019</volume>, <fpage>1957920</fpage>. <pub-id pub-id-type="doi">10.1155/2019/1957920</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harhausen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Prinz</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gertz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Endres</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lehrach</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>CD93/AA4.1: A novel regulator of inflammation in murine focal cerebral ischemia</article-title>. <source>J. Immunol.</source> <volume>184</volume>, <fpage>6407</fpage>&#x2013;<lpage>6417</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0902342</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausenloy</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Yellon</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Myocardial ischemia-reperfusion injury: A neglected therapeutic target</article-title>. <source>J. Clin. Invest.</source> <volume>123</volume>, <fpage>92</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1172/JCI62874</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hochberg</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Benjamini</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>More powerful procedures for multiple significance testing</article-title>. <source>Stat. Med.</source> <volume>9</volume>, <fpage>811</fpage>&#x2013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1002/sim.4780090710</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fiser</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dimmick</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Loeher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pircher</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction</article-title>. <source>PLoS One</source> <volume>7</volume>, <fpage>e47155</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047155</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adah</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tariq</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>CXCL13/CXCR5 signaling axis in cancer</article-title>. <source>Life Sci.</source> <volume>227</volume>, <fpage>175</fpage>&#x2013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2019.04.053</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarrah</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Schwarskopf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>LaRocca</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dhume</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>SDF-1 induces TNF-mediated apoptosis in cardiac myocytes</article-title>. <source>Apoptosis</source> <volume>23</volume>, <fpage>79</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1007/s10495-017-1438-3</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kristiansen</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Haanes</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Sheykhzade</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Edvinsson</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Endothelin receptor mediated Ca(2&#x2b;) signaling in coronary arteries after experimentally induced ischemia/reperfusion injury in rat</article-title>. <source>J. Mol. Cell. Cardiol.</source> <volume>111</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2017.07.013</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krzywinski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Birol</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gascoyne</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Horsman</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Circos: An information aesthetic for comparative genomics</article-title>. <source>Genome Res.</source> <volume>19</volume>, <fpage>1639</fpage>&#x2013;<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1101/gr.092759.109</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wernersson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Slodkowicz</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A scored human protein-protein interaction network to catalyze genomic interpretation</article-title>. <source>Nat. Methods</source> <volume>14</volume>, <fpage>61</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.4083</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>CaSR activates PKC&#x3b4; to induce cardiomyocyte apoptosis via ER stress&#x2011;associated apoptotic pathways during ischemia/reperfusion.</article-title> <source>Int. J. Mol. Med.</source> <volume>44</volume>, <fpage>1117</fpage>&#x2013;<lpage>1126</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2019.4255</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattiazzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Argenziano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aguilar-Sanchez</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mazzocchi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Ca2&#x2b; Sparks and Ca2&#x2b; waves are the subcellular events underlying Ca2&#x2b; overload during ischemia and reperfusion in perfused intact hearts</article-title>. <source>J. Mol. Cell. Cardiol.</source> <volume>79</volume>, <fpage>69</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.10.011</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moran</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Forouzanfar</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Mensah</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Ezzati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Flaxman</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The global burden of ischemic heart disease in 1990 and 2010: The global burden of disease 2010 study</article-title>. <source>Circulation</source> <volume>129</volume>, <fpage>1493</fpage>&#x2013;<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.004046</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1&#x3b1; signalling.</article-title> <source>J. Cell. Mol. Med.</source> <volume>24</volume>, <fpage>850</fpage>&#x2013;<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.14795</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>F. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis</article-title>. <source>J. Cell. Physiol.</source> <volume>236</volume>, <fpage>1309</fpage>&#x2013;<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.29938</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raudvere</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kolberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kuzmin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Arak</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update).</article-title> <source>Nucleic Acids Res.</source> <volume>47</volume>, <fpage>W191</fpage>&#x2013;<lpage>W198</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Phipson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res.</source> <volume>43</volume>, <fpage>e47</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Modelling patterns of agreement for nominal scales</article-title>. <source>Stat. Med.</source> <volume>27</volume>, <fpage>810</fpage>&#x2013;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1002/sim.2945</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saldanha</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Java Treeview--extensible visualization of microarray data</article-title>. <source>Bioinformatics</source> <volume>20</volume>, <fpage>3246</fpage>&#x2013;<lpage>3248</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bth349</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markiel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozier</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Cytoscape: A software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res.</source> <volume>13</volume>, <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Chemokine CXCL13 acts via CXCR5-ERK signaling in hippocampus to induce perioperative neurocognitive disorders in surgically treated mice</article-title>. <source>J. Neuroinflammation</source> <volume>17</volume>, <fpage>335</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-020-02013-x</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Heat shock protein 70 protects the heart from ischemia/reperfusion injury through inhibition of p38 MAPK signaling</article-title>. <source>Oxid. Med. Cell. Longev.</source> <volume>2020</volume>, <fpage>3908641</fpage>. <pub-id pub-id-type="doi">10.1155/2020/3908641</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stark</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Breitkreutz</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Reguly</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Breitkreutz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tyers</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>BioGRID: A general repository for interaction datasets</article-title>. <source>Nucleic Acids Res.</source> <volume>34</volume>, <fpage>D535</fpage>&#x2013;<lpage>D539</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkj109</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>102</volume>, <fpage>15545</fpage>&#x2013;<lpage>15550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Calcium-sensing receptor-mediated mitogen-activated protein kinase pathway improves the status of transplanted mouse embryonic stem cells in rats with acute myocardial infarction</article-title>. <source>Mol. Cell. Biochem.</source> <volume>431</volume>, <fpage>151</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-017-2987-z</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turei</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Korcsmaros</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Saez-Rodriguez</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>OmniPath: Guidelines and gateway for literature-curated signaling pathway resources</article-title>. <source>Nat. Methods</source> <volume>13</volume>, <fpage>966</fpage>&#x2013;<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.4077</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Raemdonck</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Umar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Palasiewicz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Volkov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Volin</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Arami</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>77</volume>, <fpage>1387</fpage>&#x2013;<lpage>1399</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-019-03235-w</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vekemans</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van Pelt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Komuta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wylin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Heedfeld</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Detry</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Attempt to rescue discarded human liver grafts by end ischemic hypothermic oxygenated machine perfusion</article-title>. <source>Transpl. Proc.</source> <volume>43</volume>, <fpage>3455</fpage>&#x2013;<lpage>3459</lpage>. <pub-id pub-id-type="doi">10.1016/j.transproceed.2011.09.029</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. W.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Dexmedetomidine attenuates ischemia/reperfusion-induced myocardial inflammation and apoptosis through inhibiting endoplasmic reticulum stress signaling</article-title>. <source>J. Inflamm. Res.</source> <volume>14</volume>, <fpage>1217</fpage>&#x2013;<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.2147/JIR.S292263</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>40</volume>, <fpage>599</fpage>&#x2013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1038/s41401-018-0082-y</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kakizaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoshie</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Identification of single C motif-1/lymphotactin receptor XCR1</article-title>. <source>J. Biol. Chem.</source> <volume>273</volume>, <fpage>16551</fpage>&#x2013;<lpage>16554</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.26.16551</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q. C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling</article-title>. <source>Drug Des. devel. Ther.</source> <volume>13</volume>, <fpage>3137</fpage>&#x2013;<lpage>3149</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S219533</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>F. H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-&#x43a;B signaling pathway</article-title>. <source>PLoS One</source> <volume>12</volume>, <fpage>e0172006</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0172006</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>MCP-1 mediates ischemia-reperfusion-induced cardiomyocyte apoptosis via MCPIP1 and CaSR</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol.</source> <volume>318</volume>, <fpage>H59</fpage>&#x2013;<lpage>H71</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00308.2019</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A GPR174-CCL21 module imparts sexual dimorphism to humoral immunity</article-title>. <source>Nature</source> <volume>577</volume>, <fpage>416</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1873-0</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pache</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khodabakhshi</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Tanaseichuk</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title>. <source>Nat. Commun.</source> <volume>10</volume>, <fpage>1523</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuberi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Franz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Montojo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>G. D.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>GeneMANIA prediction server 2013 update</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>W115</fpage>&#x2013;<lpage>W122</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt533</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>